Locate your nearest distributor

Location:
Type:
Text search:
Username:
Password:
Forgot password?

News Archive

More scientific evidence on GastroPanel® test – the test predicts gastric cancer risk even at 15-year follow-up

23.05.2016 13:45

More scientific evidence on GastroPanel® test – the test predicts gastric cancer risk even at 15-year follow-up
 
Biohit Oyj Press Release May 23, 2016 at 01:45 pm local time (EEST) 
 
Low Pepsinogen I level diagnosed with GastroPanel® test predicts the risk for stomach cancer even years in advance. The result is evident in two separate recent studies among Asian and Caucasian population, where the subjects were followed-up for several years after GastroPanel® testing. Low Pepsinogen I level in the blood sample accompanied by high Gastrin-17 level, is a sign of atrophic gastritis of the corpus. The latter is known to be a risk factor for gastric cancer. The long-term predictive value of GastroPanel® test as a predictor of this risk has not been previously confirmed in a Caucasian population.  
 
Read more